Panaxydol linoleate



Compound IDCDAMM01330
Common namePanaxydol linoleate
IUPAC name8-(3-heptyloxiran-2-yl)oct-1-en-4,6-diyn-3-yl octadeca-9,12-dienoate
Molecular formulaC35H54O3

Experimental data

Retention time19.33
Adduct[M+H]+
Actual mz523.414
Theoretical mz523.414
Error0.15
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.2382

Identifiers and class information

Inchi keyMGQITZGZKLABCX-XUPYMNJSNA-N
SmilesO=C(OC(C#CC#CCC1OC1CCCCCCC)C=C)CCCCCCCC=CCC=CCCCCC
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)25
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)522.81
Computed dipole moment(dipole)2.419
Total solvent accessible surface area (SASA)1243.82
Hydrophobic component of SASA (FOSA)1069.79
Hydrophilic component of SASA (FISA)45.66
Pie component of the SASA (PISA)128.372
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2162.59
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4
Free energy of solvation of dipole (dip^2/V)0.0027061
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.650213
Predicted polarizability in cubic angstroms (QPpolrz)65.566
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.865
Predicted octanol/gas partition coefficient (QPlogPoct)22.229
Predicted water/gas partition coefficient (QPlogPw)2.322
Predicted octanol/water partition coefficient (QPlogPo/w)11.29
Predicted aqueous solubility (QPlogS)-13.623
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.191
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.804
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3655.14
Predicted brain/blood partition coefficient (QPlogBB)-1.663
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2008.09
Predicted skin permeability, log Kp (QPlogKp)0.491
PM3 calculated ionization potential (IP(ev))9.854
PM3 calculated electron affinity (EA(eV))-0.067
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)2.764
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)47.94
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P17612PRKACAcAMP-dependent protein kinase alpha-catalytic subunitT12808SEA
P21554CNR1Cannabinoid receptor 1 (by homology)T76685SEA
O00519FAAHAnandamide amidohydrolaseT11754SEA
P04035HMGCRHMG-CoA reductaseT53585SEA
Q02156PRKCEProtein kinase C epsilonT00895SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
Q8TDS5OXER1Oxoeicosanoid receptor 1T68834SEA
Q9Y4D2DAGLASn1-specific diacylglycerol lipase alphaT03150SEA
Q13822ENPP2AutotaxinT63512SEA
Q9HBW0LPAR2Lysophosphatidic acid receptor Edg-4T39380SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA
Q9UP65PLA2G4CCytosolic phospholipase A2 gammaT91113SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T12808DI0279Muscular atrophy[ICD-11: 8B61]P17612PRKACA
T76685DI0031Anorexia nervosa[ICD-11: 6B80]P21554CNR1
T76685DI0214Insomnia[ICD-11: 7A00-7A0Z]P21554CNR1
T76685DI0308Obesity[ICD-11: 5B80-5B81]P21554CNR1
T11754DI0101Corneal disease[ICD-11: 9A76-9A78]O00519FAAH
T53585DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P04035HMGCR
T53585DI0102Coronary atherosclerosis[ICD-11: BA52]P04035HMGCR
T53585DI0128Dyslipidemia[ICD-11: 5C80-5C81]P04035HMGCR
T53585DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P04035HMGCR
T53585DI0275Multiple sclerosis[ICD-11: 8A40]P04035HMGCR
T53585DI0287Myocardial infarction[ICD-11: BA41-BA43]P04035HMGCR
T53585DI0324Pain[ICD-11: MG30-MG3Z]P04035HMGCR
T00895DI0033Anxiety disorder[ICD-11: 6B00-6B0Z]Q02156PRKCE
T00895DI0243Malaria[ICD-11: 1F40-1F45]Q02156PRKCE
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T63512DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q13822ENPP2
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1

Copyright © 2025